// App-Quantinova.ai

3036 : Relationship of baseline tumoral IFN mRNA and PD-L1 protein expression to overall survival in durvalumab-treated NSCLC patients.

Researchers

Presenter

  • Brandon W Higgs

Principal Investigators

  • Chris Morehouse

  • Katie Streicher

  • Marlon C. Rebelatto

  • Keith Steele

  • Xiaoping Jin

  • Fernanda Pilataxi

  • Philip Z. Brohawn

  • John A. Blake-Haskins

  • Ashok Kumar Gupta

  • Koustubh Ranade

Medical Centers

  • MedImmune, Gaithersburg, MD

  • MedImmune, Gaithersburg, MD

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

  • Non Small Cell Lung cancer

Biomarkers

  • Phosphatase and tensin homolog

  • Programmed death-ligand 1

Drug/Treatment

  • Durvalumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • NCT01693562

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved